Company Filing History:
Years Active: 1991-2005
Title: Christopher G Boissard: Innovator in Pharmaceutical Chemistry
Introduction
Christopher G Boissard is a notable inventor based in Northford, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that focus on innovative treatments for various medical conditions. His work is characterized by a commitment to advancing therapeutic options through chemical innovation.
Latest Patents
Boissard's latest patents include "Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives." This patent describes atropisomers that can modulate large conductance calcium-activated K channels, which are useful in treating disorders responsive to the opening of potassium channels. These atropisomers are notable for their stability, remaining unchanged for periods of up to one month or more. Another significant patent is the "Method of treatment of ischemia in brain," which outlines a process for protecting brain cells from ischemia and treating ischemic and degenerative brain disorders through the systemic administration of BMY 14802 or its pharmaceutically acceptable salts.
Career Highlights
Christopher G Boissard is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this esteemed organization has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Boissard has collaborated with esteemed colleagues, including Duncan P Taylor and Michael S Eison. These collaborations have fostered an environment of innovation and have led to advancements in their respective fields.
Conclusion
Christopher G Boissard is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and innovative treatments. His contributions continue to impact the medical field positively, showcasing the importance of research and development in healthcare.